Stockreport

NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA

ABLIVA AB  (NEVPF) 
NASDAQ:AMEX Investor Relations: neurovive.com/investor
PDF LUND, Sweden, May 10, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, F [Read more]